Skip to content

Author

M. Southey

We have 4 of 882 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Epigenetic Predictors of Smoking: External Validation and Association With Smoking-Related Cancer Risk.

Tobacco smoking has a strong influence on DNA methylation (DNAm), enabling the development of DNAm-based smoking predictors, yet external evaluations of these have remained limited. We aimed to assess six DNAm-based smoking predictors in a large sample of middle-aged and older Australians for (i) their accuracy and rel...

Xiao-Yu Fan, D. L. Li, Allison M. Hodge et al. · 0 citations
Review Open access Oct 2026

Importance of faecal sample collection in prospective cohort studies to evaluate the effect of the gut microbiome on cancer development.

The gut microbiome has been linked to cancer in many cross-sectional studies. These studies compared individuals with and without cancer, but they do not establish causation. Prospective cohort studies, with faecal samples collected before a cancer diagnosis, will be instrumental in assessing the role of the gut microb...

E. Vogtmann, Caroline Y. Um, S. Zouiouich et al. · 0 citations
Open access Sep 2026

Circulating Inflammatory Markers and Mammographic Density Phenotypes: a Mendelian Randomization Analysis

A comprehensive analysis of 60 CIMs provides limited evidence supporting broad causal effects of circulating inflammatory markers contributing to variation in MD phenotypes, although most instruments demonstrated weak conditional instrument strength after inclusion of BMI.

A. H. Suger, T. Harrison, C. Haas et al. · 0 citations
Open access Aug 2026

Integration of lipidomic and polygenic risk scores within contemporary clinical cardiovascular risk assessment pathways: a multi-cohort development and validation study

This investigation investigated whether selective integration of lipidomic and genomic risk signals into AusCVDRisk improves 5-year CVD prediction and reclassification, with a focus on individuals at intermediate clinical risk.

Aleksandar Dakic, Jing-Qin Wu, Ting-Ting Wang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.